Tag: CIRSE 2024
Quality over quantity? The growing focus on QoL in interventional oncology
A focus session dedicated to quality-of-life (QoL) outcomes in interventional oncology (IO) at this year’s Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual...
WAVE trial reports Wrapsody superiority over standard PTA
Six-month results of the WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial have reported superior target lesion primary patency (TLPP) with Wrapsody (Merit Medical) cell-impermeable...
“Game-changing” six-month SUCCESS PTA results report Selution SLR efficacy
The first report of six-month results from the SUCCESS PTA trial evaluating the Selution SLR (Cordis) drug-eluting balloon has shown that consistent haemodynamic, functional...
Merit Medical’s Wrapsody WAVE trial demonstrates superior patency versus standard of...
Merit Medical has today announced positive six-month findings from the randomised arteriovenous (AV) fistula arm of its Wrapsody Arteriovenous Access Efficacy (WAVE) pivotal trial....
Mechanical thrombectomy shifts the needle toward interventional management of PE and...
This advertorial is sponsored by Inari Medical.
Evaluating the current standard of care for the management of acute pulmonary embolism (PE) and deep vein thrombosis...
